Abstract. In an area of Papua New Guinea with high prevalence of Plasmodium falciparum (39.6%), Plasmodium vivax (18.3%), and Plasmodium malariae (13.8%), cross-sectional analysis found P. falciparum infection to be independent of the other species despite heterogeneities in transmission. Plasmodium vivax and P. malariae infections were negatively correlated. Plasmodium malariae infection was positively associated with homologous infection four months previously and with prior P. falciparum, but not P. vivax infection. There were no other indications that any Plasmodium species protected against heterologous infection. Prospective analysis of health-center morbidity supported the idea that P. malariae infection protects against disease, but indicated greater protection against non-malaria than P. falciparum-associated fevers. Plasmodium vivax appeared to protect against P. falciparum disease but not against other forms of morbidity. Covariate adjustment had considerable effects on estimated relationships between species, and confounding variables may account for many differences among reports of inter-species interactions in human malaria.
INTRODUCTION
Malaria in humans can be caused by any of four species of Plasmodium: P. vivax, P. ovale, P. malariae, and P. falciparum, and it has long been known that infection with one of these can affect susceptibility to the others, although these interactions have never been well understood. 1 Many field studies have found a correlation between the presence of malaria parasites of different species in the same human host. Positive correlations between exposure to and hence prevalence of different species of Plasmodium might be expected, because they are all transmitted by the same mosquitoes. However malariologic surveys frequently find fewer mixed infections than expected based on the hypothesis of independence. 2 A recent analysis of point-prevalence data from 35 studies of human populations found that for the P. falciparum-P. vivax pair, a higher overall prevalence is associated with fewer mixed-species infections than would be expected on the basis of individual species prevalences. 3 This may in part be due to immunologically cross-reactive epitopes between P. falciparum and P. vivax. 4 However, there was no negative correlation for the P. falciparum-P. malariae, 3 and longitudinal studies indicate that malarial parasites can also favourably affect the host environment for other species. 5, 6 Summarizing the literature available in 1988, Richie 1 argued that suppression of one species by another could be a result of competition for nutrients or for host cells, or of an immune-mediated ceiling to parasite density. A similar hypothesis for the latter has recently been invoked to account for patterns of parasite densities in mixed-species infections in the Madang area of Papua New Guinea (PNG). 7 The successive appearance of different species in the same host more often than expected by chance could also result from immune suppression of heterologous parasites. Reciprocity in the seasonality of P. falciparum and P. vivax in Vanuatu 8 and in P. falciparum and P. malariae in Garki, Nigeria 5 have been considered as the result of dry-season decreases in P. falciparum prevalence, which allows parasites of other species to become patent. Alternative explanations for such correlations between Plasmodium species include genetic heterogeneity in the host, biases in slidereading, or the predilection of P. vivax for reticulocytes.
Few studies have clearly distinguished between the effects of infection with a second species on protection against infection and protection against malaria disease, and most such studies have considered infection at only a single point in time. For instance, Black and others 9 suggested that P. malariae protects against clinical P. falciparum malaria on the basis of a case-control study, comparing the frequency of co-infection with P. malariae during clinical attacks of P. falciparum with that of individuals with asymptomatic P. falciparum infections. However, this design cannot determine if the low prevalence of P. malariae infection in clinical P. falciparum cases is a result of a protective effect of P. malariae or of suppression of P. malariae by non-specific responses to P. falciparum. There is a clear need for prospective analyses, since much stronger evidence for causality in epidemiologic studies is provided when the temporal order of events is recorded. 10 From 1990-1992 a series of seven community malariologic surveys were carried out in 10 villages in the Wosera area of PNG. 11 Peripheral malaria parasitemia was found in 60% of individuals. Fifty-five percent of malaria infections were P. falciparum, 25% were P. vivax, and 20% were P. malariae. At the same time, morbidity was assessed at a health sub-center within the area. [12] [13] [14] We have now done cross-sectional and prospective analyses of infections and parasites in this area, and have used health center data to analyze the prospective risk of clinical attacks with P. falciparum in relation to prior infections recorded at the community surveys.
MATERIALS AND METHODS
Study area and population. The study was carried out in the Wosera area of East Sepik Province of Papua New Guinea as part of the Malaria Vaccine Epidemiology and Evaluation Project of the Papua New Guinea Institute of Medical Research. 15 Starting in 1989, all residents of ten villages selected for their different levels of malarial endemicity were included in a demographic surveillance system. 11 There is little seasonal variation in temperature or rainfall in this area and malaria transmission is perennial, with a total of six different vector species. 16 Parasite prevalence of the three endemic species in the human host also showed little or no seasonality. 11 Community surveys. Seven cross-sectional epidemiologic surveys were carried out at approximately four-month intervals between July 1990 and July 1992 on samples of the population of all ten study villages. Households included were selected at random. The details of recruitment and sample sizes for each survey were given by Genton and others. 11 Ethical approval for the study was given by the Medical Research and Advisory Council of Papua New Guinea and human subjects gave oral informed consent. The surveys comprised morbidity questionnaires, clinical examinations carried out in house-to-house visits, and parasitologic assessment. A total of 10,001 parasitologic observations from individuals of all ages were available for the present analyses.
Blood slide assessment. Blood slides (thick and thin films) were prepared by finger-prick, air dried, and read after Giemsa staining using Olympus light microscopes with a ϫ100 oil immersion lens and ϫ10 eyepiece. 100 thick film fields were examined for each species prior to slides being declared negative. The same procedures were used for slides from the health center and from community surveys.
Kunjingini Sub Health Centre surveillance. Five of the study villages fall in the catchment area of the Kunjingini Sub Health Centre (KHC), and the present analyses considered clinical data only for patients from these five villages. Age, sex, place of residence, presumptive diagnosis and treatment were recorded for all outpatients at this center throughout the study period. Patients resident in study villages were identified in the demographic surveillance system. A subset of cases diagnosed as malaria-infected by the health center nurses was further investigated. 12 Most of these had measurable fever (axillary temperature Ն 37.5ЊC) or reported fever. Data collected included a detailed history, clinical examination, parasitologic assessment, haemoglobin, and packed cell volume. Presumptive malaria patients were classified according to whether P. falciparum parasites were detected or not. In addition, we considered them as hyperparasitemic episodes when P. falciparum densities were over 5,000/l. Data analysis. Health-center attenders and participants in malariologic surveys were identified on the demographic database. All available slide data were included in both crosssectional and longitudinal analyses of infection status. Analysis of morbidity risks considered only episodes reported to the health center within a follow-up period of two months from a malariologic survey, and only those patients who lived in the five villages within the recognized catchment area. Statistical analyses of relationships between species, adjusting for covariates including age, sex and village were carried out by logistic regression, using the SAS LOGISTIC procedure 17 except where indicated otherwise.
RESULTS
The age distributions of parasitemia, and the spatial patterns of occurrence of the three different Plasmodium species in the human population of Wosera have been described previously, 11, 18 as have the distributions of malaria vectors in the area, 15 and malaria infection in mosquitoes. 19 Plasmodium falciparum was observed in 3,959 samples (39.6%), P. vivax in 1,826 (18.3%), and P. malariae in 1,380 (13.8%). Co-infections of both P. vivax and P. malariae with P. falciparum were detected at almost exactly the frequencies predicted if the different species occurred independently (Table 1) . However, the presence of P. malariae or P. vivax halved the chances of the other one being detected. Plasmodium vivax was most frequently detected in very young children in this population, whereas P. malariae was most frequently detected in older children and adults. 18 Neither age nor sex adjustment with a logistic regression significantly affected the magnitude of this estimated relationship (results not shown). Nor did this adjustment affect the conclusion that there is no association of the point prevalences of P. malariae and P. falciparum. In contrast, the adjusted odds ratio measuring the association between P. vivax and P. falciparum was 0.80 (95% confidence limits [CL] 0.72, 0.89).
Positive interactions were seen when the infection data were examined longitudinally (Table 2 ) presumably reflecting the correlations in exposure. The independence of P. malariae infection from prior P. vivax infection may reflect the strong negative correlation between these two species in cross-sectional analysis, coupled with the very high serial correlation in the P. malariae data. The highest relative risk for the P. malariae-P. vivax association was to be expected since P. malariae is known to persist longer than the other species. Interestingly, although P. malariae is associated with subsequent P. vivax infection, the reverse is not the case, suggesting that P. vivax is somewhat antagonistic to the development of P. malariae.
A very different pattern was evident in the analyses of prospective risk of clinical episodes (Tables 3 and 4) . Plasmodium malariae appeared to protect against illness, whether the episode itself was positive for P. falciparum or not. Plasmodium vivax infection appeared to be protective against subsequent P. falciparum positive episodes, but not An interval was defined by two blood slides from the same individual at successive surveys. Transition type ϩϩ ϭ positive at both the start and end of the interval; ϩϪ ϭ positive at start, negative at end; Ϫϩ ϭ negative at start, positive at end; and ϪϪ ϭ negative at both start and end. The risk ratio is a measure of the strength of the relationship between the frequency of positivity at the end of the interval and that at the start of the interval, and is calculated as the ratio: where N ϩϩ is the total number of transitions of type ϩϩ, and so on. significantly against P. falciparum negative episodes. A third pattern was evident for P. falciparum. Patency with this parasite was negatively associated with subsequent aparasitemic clinical episodes, but positively associated with episodes with the homologous parasite. Logistic regression analyses were used to estimate the effect of infection at the start of the interval on the probability that an episode occurred during the interval adjusting for age and for prior health center attendance. Allowance for repeated observations on the same individual by fitting a random effect using a Generalised Estimating Equation algorithm in the SAS GENMOD procedure made no difference to these analyses (i.e., there was no over-dispersion). Sexadjustment also had little effect. These analyses provided evidence that P. malariae positivity was associated with protection against subsequent morbidity (i.e., health center attendance), however the effect was not specific for malaria morbidity, and indeed the effect was greater with aparasitemic episodes as the outcome. In contrast, P. vivax appeared to protect specifically against P. falciparum episodes.
Further analyses included adjustment for the time period (survey number) and for the village of residence. Inclusion of both or either of these factors in the regression models tended to decrease the statistical significance of the effects of P. malariae and P. vivax infection on prospective risk of morbidity, and made the estimated odds ratios closer to unity, implying that some of the apparent effects of non-falciparum malaria infections might reflect confounding by village or time period. Thus the odds ratio for P. falciparumpositive episodes associated with P. vivax infection and adjusted for these factors in addition to sex, age, and preceding attendance, increased from 0.52 to 0.63 (95% CL 0.27, 1.48; Likelihood Ratio (LR) X 2 2.0, P ϭ 0.2). In the corresponding analyses the odds ratio for P. falciparum-negative episodes associated with P. malariae infection increased from 0.23 to 0.27 (Table 4 ) (95% CL 0.07, 1.11; LR X 2 5.0, P ϭ 0.025). Where the outcome was any health center attendance, the odds ratio for P. malariae increased from 0.73 to 0.81 (95% CL 0.62, 1.05; LR X 2 2.7, P ϭ 0.098). Similarly, the odds ratio associated with P. falciparum infection in models that included these additional adjustments was 0.69 (95% CL 0.42, 1.13; LR X 2 2.3, P ϭ 0.13) compared with 0.62 when the outcome was P. falciparum-negative episodes. When the outcome was P. falciparum-positive episodes, it increased from 1.73 to 2.05 (95% CL 1.28, 3.26; LR X 2 8.9, P ϭ 0.003).
The effects of mixed infections on the prospective risk of disease were analysed by simultaneously including the ef- fects of two malaria species in the logistic regression models, and then adding an interaction term. In no cases were these interactions statistically significant.
DISCUSSION
Studies of interactions between human malaria species have a long history, with the suggestion that P. falciparum could suppress P. malariae dating back to Thomson in 1934 . 20 However, variations among the findings of different studies led Richie 1 to conclude that there are geographic differences in the way that human malaria species interact; these interactions may even change from year to year in a given location.
All human malarias are transmitted by the same vector species, and in the absence of immunologic interactions, this would lead to them occurring together more often than expected by chance. However, deficits of mixed infections have generally been recorded in areas with a P. falciparum/P. vivax/P. malariae species mix, 3, 21 suggesting that there is suppression of heterologous parasites. A recent study from a site in PNG neighboring the Wosera with all four human malaria species found no associations. 22 It is hardly surprising that the extent of association varies, since the degree of focality of transmission is variable. Minority populations of parasites are easily overlooked in mixed infections, 23 and the quality of slide reading also varies. Moreover, few studies have tested for confounding by age of the relationships between species, and in Wosera the P. falciparum-P. vivax relationship was only evident after age adjustment. It follows that considerable differences between sites in statistical correlations between species could arise, even if the biologic interactions were identical.
While most field studies of species interactions have considered only point-prevalence data, we focused on prospective longitudinal analyses, which have the advantage that they can provide evidence for causality. Temporal relationships between species are also less influenced by the difficulty of diagnosing mixed infections. Positive interactions were generally detected when the Wosera infection data were examined longitudinally (Table 2) , and presumably reflect correlations in exposure and/or in host susceptibility to the different species. Those interactions also conform to the patterns reported by Richie. 1 The notable exception that P. malariae infection was independent of prior P. vivax in Wosera may reflect merely the strong negative correlation between these two species in cross-sectional analysis, coupled with very high serial correlation in the P. malariae data. In contrast to the P. falciparum-P. malariae interactions in northern Nigeria, 5 and P. falciparum-P. vivax interactions in e.g., Vanuatu, 8 there were no seasonal differences in Wosera. 11 This was presumably because P. falciparum transmission showed little seasonality in our study area.
While longitudinal patterns of infection can be explained without specific immunologic interactions, the effect of malaria infection on the incidence of clinical episodes in Wosera is very different from the effect on infection. Such dissociation between malaria infection and disease is unexceptional 15 because infection is a necessary consequence of living in the real world. For the host, the optimal biologic strategy is therefore to accommodate the infection and avoid the disease.
Both P. vivax and P. malariae seem to protect against subsequent P. falciparum episodes, but P. malariae-associated protection appears to be non-specific and extends to other illnesses, as has been reported recently in PNG for the protection afforded by ␣ϩ-thalassemia. 24 Asymptomatic P. vivax seems to specifically protect against P. falciparum episodes, while providing little or no protection against non-malaria clinical episodes. Of possible non-immunologic explanations, the most obvious is that habitual attenders of health facilities may harbor P. vivax (or P. malariae) less often because they take anti-malarials. However, if this were the case, we would have expected the effects to be considerably reduced when the analyses were adjusted for prior health center attendance. This adjustment actually made little difference, and prior attenders were almost as likely to be infected with non-falciparum malaria as non-attenders.
Plasmodium vivax may thus be protecting against P. falciparum via immunologic cross-reactions that control P. falciparum parasite densities, while the P. malariae effect could be a consequence of down-regulation of cytokine production by this parasite, as suggested by Black and others. 9 However, there remains the possibility that genetic heterogeneity in host responses is the explanation for the P. malariae effect. This hypothesis was proposed to explain the longitudinal patterns of association between P. malariae and P. falciparum infections in Garki. 5 One possible mechanism would be that constitutively low producers of TNF-␣ tend both to sustain infections with P. malariae, and to have low incidence of fever. At the moment we are not able to distinguish between these hypotheses. Protection against P. falciparum depends on complex mechanisms involving both the afferent arm of the immune response (host genetics and malarial peptides) and end-stage molecules of the efferent arm (TNF-␣ and nitric oxide) 25, 26 . Immunologic investigations are needed to investigate ways in which P. vivax and P. malariae interact with the regulation of this system. Adjustment for village or survey could also account for the apparent protection mediated by P. vivax. The sensitivity of the results to such adjustments makes the conclusions debatable. This is not only the case for our analyses, but is an issue relevant to the interpretation of other observational studies of species interactions. Testing for age and sex effects is generally important, but village and survey effects could themselves be consequences of species interactions, so their inclusion in the model might be inappropriate.
Until it can be shown that confounding factors or host heterogeneities account for the apparent protection, the possibility remains that P. malariae and P. vivax infections act as natural vaccines against P. falciparum, perhaps pointing the way to new avenues in P. falciparum vaccine development. More immediately, our results bear on the question of whether asymptomatic malaria infections should be treated. In endemic areas such as Wosera, such infections are not treated when they are found in malariologic surveys. Standard practice in Papua New Guinea is also not to provide radical treatment of clinical P. vivax. The present results suggest that since P. vivax and P. malariae infections may provide some cross-protection against P. falciparum episodes, these policies are appropriate for controlling the burden of morbidity from P. falciparum.
